Biosimilars Documentation Form

Biosimilars Documentation Form

• Post category: Professional Resources

Preparing for the 2023 Flu Season

• Post category:  

Injections and Inhalations

• Post category: Professional Resources

OPA Welcomes Hitesh Pandya as New Chair of the Board of Directors

• Post category: Governance

OPA Position on Any Willing Provider Legislation in Ontario

• Post category: Advocacy

Calcium – Dietary Sources and Drug Interactions

• Post category: Professional Resources

Smoking Cessation

• Post category: Professional Resources

CoPIL Task Force – Terms of Reference

• Post category: Governance

Board Update – April 2023 Board Meeting

• Post category: Governance

Funding for Minor Ailment Services in Ontario Pharmacies | Supplementary FAQs

• Post category: Professional Resources

Insights into OPA’s Professional Affairs Department: Pharmacy Student Experience

• Post category: Blog

Scope of Practice for Pharmacy Professionals

• Post category: Advocacy

Board Update – February 9, 2023, Board Meeting Summary

• Post category: Governance

Nirmatrelvir/Ritonavir (Paxlovid) Prescribing – Renal Function Dosing Considerations

• Post category: Professional Resources

Ontario Pharmacists Can Now Assess and Treat Minor Ailments

• Post category: Advocacy